U.S. Clinical Trial: Women's Hospital School Of Medicine Zhejiang University Listed a New Clinical Trial to Study Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors

Press/Media: Press / Media

PeriodApr 21 2023

Media coverage

1

Media coverage

  • TitleU.S. Clinical Trial: Women's Hospital School Of Medicine Zhejiang University Listed a New Clinical Trial to Study Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date04/21/23
    URLct.moreover.com/?a=50585444737&p=1gw&v=1&x=x0UUn8KCpQAeTzicUWCq8g
    PersonsHui Wang
View all 1
View less